Reduction of AMPA-selective glutamate receptor subunits in the entorhinal cortex of patients with Alzheimer's disease pathology: a biochemical study

Brain Research
R P YasudaD M Armstrong

Abstract

Using biochemical techniques we determined concentrations of the AMPA-selective glutamate receptor subunits GluR1 and GluR2/3 in the entorhinal cortex of patients with Alzheimer's disease pathology and age-matched controls. Tangle density was also determined in anatomically matched samples and correlated with GluR1 and GluR2/3 receptor concentration. In Alzheimer's disease brain, Western blot analysis revealed average reductions of 43% and 38% for GluR1 and GluR2/3, respectively. Based on previous immunohistochemical studies, we infer that the majority of protein reduction was due to decreases in GluR1 and GluR2/3 immunolabeled elements in the more superficial layers of the entorhinal cortex (layers II and III). These layers of the entorhinal cortex contained numerous neurofibrillary tangles in Alzheimer's disease, but neither GluR1 nor GluR2/3 protein concentration correlated significantly with tangle density. We hypothesize that the decrease in specific glutamate receptor subunits, particularly GluR2/3, may contribute to the vulnerability of neurons in the entorhinal cortex via mechanisms involving calcium conductance through AMPA-selective channels.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Apr 1, 1992·Neurology·R L Albin, J T Greenamyre
Jan 1, 1991·Hippocampus·G W Van HoesenA R Damasio
Jul 1, 1990·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A M Palmer, S Gershon
Aug 3, 1990·Science·K KeinänenP H Seeburg
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·J T GreenamyreA B Young
Oct 1, 1986·Annals of Neurology·B T HymanA R Damasio

❮ Previous
Next ❯

Citations

Apr 8, 1999·Neuropharmacology·G R Seabrook, T W Rosahl
Oct 17, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C Anthony AltarStephen D Ginsberg
Feb 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Eric H ChangPatricio T Huerta
Feb 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Annalisa BernareggiRicardo Miledi
Dec 1, 2010·The Journal of Biological Chemistry·Sofia JürgensenSergio T Ferreira
Mar 9, 2007·Genome Biology·Erin L HeinzenDavid B Goldstein
Jun 30, 2001·Japanese Journal of Pharmacology·N KönigJ M Exbrayat
Aug 17, 2012·Journal of Psychiatry & Neuroscience : JPN·Timothy J RevettSatyabrata Kar
Oct 6, 2009·Molecular and Cellular Neurosciences·Zhong XiePeter Penzes
Sep 16, 2003·International Journal of Geriatric Psychiatry·Paul T Francis
Apr 7, 2020·Reviews in the Neurosciences·Diana Marcela Cuestas Torres, Fernando P Cardenas
Jun 1, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Noemí EsterasAndrey Y Abramov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.